STEVENS CAPITAL MANAGEMENT LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2016$152,000
-51.0%
27,749
-25.7%
0.01%
-50.0%
Q4 2015$310,000
+206.9%
37,340
-2.0%
0.01%
+300.0%
Q3 2014$101,000
-34.0%
38,107
+0.5%
0.00%
-25.0%
Q2 2014$153,000
+135.4%
37,908
+167.6%
0.00%
+100.0%
Q1 2014$65,00014,1640.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2016
NameSharesValueWeighting ↓
Belmont Global Advisors, Inc. 2,564,925$11,132,0008.99%
Essex Woodlands Management, Inc. 2,764,908$11,330,0005.70%
Third Security, LLC 17,815,708$77,320,0003.68%
MSD Partners, L.P. 2,750,000$11,935,0000.49%
SFMG, LLC 99,850$433,0000.15%
GM Advisory Group, LLC 12,500$54,0000.06%
Geduld E E 25,000$109,0000.05%
WESTPORT RESOURCES MANAGEMENT INC 30,500$132,0000.04%
Janney Montgomery Scott LLC 335,571$1,456,378,0000.04%
WFG Advisors, LP 48,040$208,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders